Tixagevimab Antibody
Tixagevimab is a humanized monoclonal antibody that neutralizes SARS-CoV-2 by binding to the spike protein's receptor-binding domain, preventing viral entry. It is utilized in research applications for both in vitro neutralization assays and in vivo preclinical studies of COVID-19 therapeutics and prophylaxis.
Product Specifications
Product Name Alternative
AZD8895, AZD 8895
Target
SARS-CoV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
10.61 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
146.48 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
